Par Pharmaceutical Companies, Inc. (NYSE:PRX)

CAPS Rating: 3 out of 5

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

Recs

0
Player Avatar reddingrunner (81.93) Submitted: 1/18/2011 11:03:18 PM : Outperform Start Price: $36.78 PRX Score: +9.07

lak/estrev+5/1.4b/A/genericRx

Featured Broker Partners


Advertisement